|
IFT74 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.66533453693773E-15 |
| Normal-vs-Stage2 |
5.03249997230171E-09 |
| Normal-vs-Stage3 |
8.88178419700125E-16 |
| Normal-vs-Stage4 |
1.64357416565508E-12 |
| Stage1-vs-Stage2 |
7.740000E-01 |
| Stage1-vs-Stage3 |
2.513600E-02 |
| Stage1-vs-Stage4 |
4.024900E-03 |
| Stage2-vs-Stage3 |
2.161200E-01 |
| Stage2-vs-Stage4 |
8.534400E-02 |
| Stage3-vs-Stage4 |
5.039800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
4.9577999999828E-06 |
| Normal-vs-Asian |
4.99829999611734E-08 |
| Caucasian-vs-AfricanAmerican |
5.077600E-01 |
| Caucasian-vs-Asian |
1.134440E-01 |
| AfricanAmerican-vs-Asian |
6.662800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.49102952207159E-13 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
6.769800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63646873829748E-12 |
| Normal-vs-Age(41-60Yrs) |
2.1094237467878E-15 |
| Normal-vs-Age(61-80Yrs) |
1.63358215843346E-12 |
| Normal-vs-Age(81-100Yrs) |
4.17360000000144E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.657400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.414000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.618400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.559400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.144000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.885600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.555300E-04 |
| Classical-VS-Follicular |
6.873800E-01 |
| Classical-VS-Other |
5.637200E-01 |
| Classical-VS-Normal |
5.57099921749682E-11 |
| Tall-VS-Follicular |
1.122210E-03 |
| Tall-VS-Other |
2.256100E-02 |
| Tall-VS-Normal |
1.94289029309402E-14 |
| Follicular-VS-Other |
6.946400E-01 |
| Follicular-VS-Normal |
4.89070006715053E-10 |
| Other-VS-Normal |
1.547760E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-14 |
| Normal-vs-N1 |
2.27009522291155E-11 |
| N0-vs-N1 |
3.496400E-01 |
|
|
